Skip Navigation



NDT Advance Access published online on December 29, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfi314
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/3/616    most recent
gfi314v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zhou, H.
Right arrow Articles by Hishida, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, H.
Right arrow Articles by Hishida, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received August 8, 2005
Accepted November 11, 2005

Original Article

Urinary maker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats

Hua Zhou 1, Akihiko Kato 1, Takehiko Miyaji 1, Hideo Yasuda 1, Yoshihide Fujigaki 1, Tatsuo Yamamoto 1, Katsuhiko Yonemura 1, Satoru Takebayashi 2, Hiroyuki Mineta 2, and Akira Hishida 1 *

1 First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
2 Department of Otolaryngology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

* To whom correspondence should be addressed.
Akira Hishida, E-mail: ahishida{at}hama-med.ac.jp



  Abstract

Background. Establishment of non-invasive urinary biomarkers for the prediction of acute renal failure (ARF) is important. We evaluated whether urinary oxidative stress markers reflect intrarenal oxidative stress in cisplatin (CDDP)-induced ARF, and whether these markers can be used for the prediction of future ARF.

Methods. Urinary malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) were measured up to day 14 post-CDDP (6 mg/kg) injection in rats. MDA and 8-OHdG expressions were examined in kidneys.

Results. CDDP induced an increase in serum creatinine (Scr), blood urea nitrogen (BUN), and tubular damage at day 5, increased urinary MDA excretion and MDA expression in kidneys at day 1 (but returned to basal values by day 3), increased urinary excretion of 8-OHdG at day 5 till day 14 (though the number of 8-OHdG-positive tubular cells increased at day 5 and then gradually decreased). Urinary MDA levels at day 1 correlated significantly with Scr ({rho} = 0.721, P<0.01) and tubular damage score ({rho} = 0.840, P<0.01) at day 5.

Conclusion. Our findings demonstrated divergent changes of urinary oxidative stress markers in CDDP-induced ARF, and suggested that urinary MDA may be a useful marker for the prediction of the development of CDDP-induced ARF.

Keywords: acute renal failure; cisplatin; malondialdehyde; 8-OHdG; urinary oxidative stress biomarker.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
E. H. Bae, J. Lee, S. K. Ma, I. J. Kim, J. Frokiaer, S. Nielsen, S. Y. Kim, and S. W. Kim
{alpha}-Lipoic acid prevents cisplatin-induced acute kidney injury in rats
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2692 - 2700.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.